EMCURE
EMCURE PHARMACEUTICALS LHealthcare
LTP
1,981
CHG · %
+2.6 (+0.13%)
VOL · TODAY
1.55L
PREV CLOSE
1,978.4
Today's range1,976.8 · 2,048
1,981
52-week range1,260 · 2,048
1,981
Loading candles…
Emcure Pharmaceuticals Ltd, incorporated in 1981, is a vertically integrated pharmaceutical company that develops, manufactures, and markets a diverse range of pharmaceutical products. Its offerings include differentiated and complex generics across several key therapeutic areas such as gynaecology, cardiovascular, vitamins, minerals and nutrients, HIV/AIDS, and oncology. The company operates globally with significant presence in India, Europe, and Canada. Emcure holds a leading position in the Indian Pharmaceutical Market (IPM), notably as the largest player in gynaecology within the IPM and is recognized among the top 10 companies in this market. It has strong research and development capabilities and focuses on addressing unmet medical needs within the pharmaceutical industry.
This page is a live market overview for EMCURE PHARMACEUTICALS L (EMCURE) on the NSE. As a listed security, EMCURE PHARMACEUTICALS L is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for EMCURE before placing trades on tick2trade.
As of the latest feed, EMCURE last traded at ₹1,981 on NSE, up ₹2.6 (0.13%) from the previous close of ₹1,978.4. Today's session range is ₹1,976.8 – ₹2,048, against a 52-week band of ₹1,260 – ₹2,048. Traded volume today stands at 1.55L shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for EMCURE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether EMCURE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for EMCURE PHARMACEUTICALS L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in EMCURE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated EMCURE option chain page linked from this overview.
// similar in healthcare317 total
SUNPHARMADIVISLABTORNTPHARMAPOLLOHOSPCIPLAZYDUSLIFEMAXHEALTHLUPINMANKINDLAURUSLABSDRREDDYAUROPHARMAMANIPALHOSFORTISBIOCONALKEMGLENMARKABBOTINDIAANTHEMASTERDM
show more (+297)show less
GLAXOGLANDAJANTPHARMIPCALABMEDANTANHKIMSLALPATHLABWOCKPHARMASAILIFEPPLPHARMANEULANDLABACUTAASRUBICONPFIZERGRANULESASTRAZENCAPLIPOINTERISONESOURCEPOLYMEDAGARWALEYECOHANCEALIVUSNATCOPHARMAPLLTDSYNGENERAINBOWSHILPAMEDJUBLPHARMACONCORDBIOVIJAYAINDGNCORONAPARKHOSPSMARKSANSVIYASHMETROPOLISAKUMSBLUEJETJLHLHCGSANOFICONRPGHLTHYROCARESTARSUVENYATHARTHSANOFIAARTIPHARMSUPRIYANEPHROPLUSSPARCKOVAISENORESFDCINNOVACAPORCHPHARMABLISSGVSARTEMISMEDIOLCPRPGLIFEZOTAMOREPENLABGUFICBIOGUJTHEMNOVARTINDAARTIDRUGSINDRAMEDCOUNICHEMLABSMSPHARMAADVENZYMESKPLDCALVIMTALABSHIKALDRAGARWQSAIPARENTBETAPANACEABIOFISCHERSOLARANGLFINEHESTERBIOINDSWFTLABSAKARINDOCOVENUSREMFREDUNKMCSHILKRSNAAWINDLASSHUKRAPHARSHALBYTARSONSFERMENTAJAGSNPHARMAMRUTANJANSURAKSHASYNCOMFGPTHEALTHQLINEUNIHEALTHLAXMIDENTLLINCOLNONEGLOBALBAJAJHCAREGKSL3BBLACKBIOTHEMISMEDREMUSHEALTHXSIGACHIBPLPHARMAGAUDIUMIVFWANBURYKOPRANSGRLANUHPHRAHCLDENTALKARTKRMAYURVEDOSELDEVICEBAFNAPHINFLUXKILITCHFABTECHAMANTAZIMLABCHANDANAPPLJENBURPHALBERTDAVDHALEOSLABSMEDICOAMBALALSATRANSCHEMVALIANTLABCCMEASTALLTDINFINIUMTAKEBDHMEDICAMEQNURECATLLEVERESTOASTONEALABAPRAMEYAZENOTECHLOTUSEYELYKALABSSANJIVINAAREYDRUGSGENNEXQMSMEDIACCPLKERALAYURCORALABNECLIFEMADHAVBAUGOXYGENTAPHEARKARTSATKARTARBMLLNATCAPSUQNOVELIXBROOKSACHYUTGUJINJECSYSCHEMJSTLPANCHSHEELPARNAXLABABATEASSMRUTHIORGBIQUESTLABAUROLABBALPHARMAALPACHOKSISTARIMAGINKIMIABLAVIENCEBALAXINEPHROCARETYCHEPARLACTOSEPHARMAIDKREBSBIOASPIRAVAISHALIGODAVARISOTACMERCURYLABINVICTAMAKERSLDENISCHEMCONCORDJFLLIFEFORTISMLRVEERHEALTHCURISMAITREYAONYXCHOKSILAAMWILLMDRCSAMRATPHSUNLOCZENITHDRUGSOURCENTRLBIBCLVINEETLABSUNRESTMHHLVILINBIOSANGANISHANMUGAKABRADGROYALVRLPHRMASISHREEPACBIOFILCHEMVIVOBIOTSHELTERKMSMEDIMANGALAMAATMAJANGVIVIMEDLABPARMAXRAJNISHGLPLVISTAPHLASANGINDSANDUPHQROOPAINDBANDARAMSHARMEHWALPARMEDICAPQSMLMEDIORGCSURGSUDECCANWELCUREGUJTERCGKBCMMHOSPTEJNAKSHGMLSAMSRITACENTUPLECHCLSDLADESHWARBACPHARISHITADRSHREEGANESCOLINZVENMAXTRABINIDANVINRKLBZENITHHEDESHRAKMONOPHARMADPLGLHRLFAMILYCAREORTINGLOBEBERLDRGDOLPHMEDUNJHAFORSTARSOURCELOOKSZDHJERKGVBLCTLLABADLINEVIVANZADECIPHERDLCLBRAWNASHRAMGIANLIFETRANSPACTSHYAMACOMPADVIKLABOSTONCRESANTOTRIPR
Frequently asked questions
- What is the current price of EMCURE?
- EMCURE last traded at ₹1,981 on NSE. The previous close was ₹1,978.4. Prices refresh throughout market hours on this overview page.
- What is today's trading range for EMCURE?
- The session low is ₹1,976.8 and the session high is ₹2,048. The 52-week range spans ₹1,260 to ₹2,048, giving longer-term context for today's move.
- Where can I see the EMCURE option chain?
- A mini option chain appears in the right column when derivatives data is available. For the full chain with greeks, max pain and PCR, visit the dedicated EMCURE option chain page or open tick2trade.
- What data is shown on the EMCURE PHARMACEUTICALS L overview page?
- The page includes live LTP, day and 52-week ranges, traded volume, an interactive price chart, market depth, recent news, corporate events and related stocks in the same sector.
- Which sector is EMCURE PHARMACEUTICALS L in?
- EMCURE PHARMACEUTICALS L is tracked in the Healthcare segment on NSE. Use the related-stocks section at the bottom of this page to compare peers in the same industry cluster.
- Is tick2trade free to use for EMCURE quotes?
- Yes — this overview page is free to access. Live prices, charts and the panels on this page do not require a login. Advanced execution, strategy building and full-depth analytics are available in the tick2trade terminal.